Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-23
2009-11-03
Lewis, Patrick T (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S315000, C514S317000, C514S319000, C514S320000
Reexamination Certificate
active
07612096
ABSTRACT:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4215114 (1980-07-01), Szmuszkovicz et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5134127 (1992-07-01), Stella et al.
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5385901 (1995-01-01), Kaplan et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5593990 (1997-01-01), D'Amato
patent: 5629327 (1997-05-01), D'Amato
patent: 5635517 (1997-06-01), Muller et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5698579 (1997-12-01), Muller
patent: 5703092 (1997-12-01), Xue et al.
patent: 5712291 (1998-01-01), D'Amato
patent: 5733566 (1998-03-01), Lewis
patent: 5798368 (1998-08-01), Muller et al.
patent: 5874448 (1999-02-01), Muller et al.
patent: 5877200 (1999-03-01), Muller
patent: 5929117 (1999-07-01), Muller et al.
patent: 5955476 (1999-09-01), Muller et al.
patent: 6015557 (2000-01-01), Tobinick et al.
patent: 6071948 (2000-06-01), D'Amato
patent: 6177077 (2001-01-01), Tobinick
patent: 6228879 (2001-05-01), Green et al.
patent: 6281230 (2001-08-01), Muller et al.
patent: 6316471 (2001-11-01), Muller et al.
patent: 6335349 (2002-01-01), Muller et al.
patent: 6379666 (2002-04-01), Tobinick
patent: 6380239 (2002-04-01), Muller et al.
patent: 6395754 (2002-05-01), Muller et al.
patent: 6403613 (2002-06-01), Man et al.
patent: 6419934 (2002-07-01), Tobinick
patent: 6419944 (2002-07-01), Tobinick
patent: 6420414 (2002-07-01), D'Amato
patent: 6423321 (2002-07-01), Tobinick
patent: 6428787 (2002-08-01), Tobinick
patent: 6458810 (2002-10-01), Muller et al.
patent: 6469045 (2002-10-01), D'Amato
patent: 6471961 (2002-10-01), Tobinick
patent: 6476052 (2002-11-01), Muller et al.
patent: 6537549 (2003-03-01), Tobinick
patent: 6555554 (2003-04-01), Muller et al.
patent: 6623736 (2003-09-01), Tobinick
patent: 6635250 (2003-10-01), Olmarker et al.
patent: 6673828 (2004-01-01), Green et al.
patent: 2001/0004456 (2001-06-01), Tobinick
patent: 2001/0016195 (2001-08-01), Tobinick
patent: 2001/0026801 (2001-10-01), Tobinick
patent: 2001/0056114 (2001-12-01), D'Amato
patent: 2002/0045643 (2002-04-01), Muller et al.
patent: 2002/0052398 (2002-05-01), D'Amato
patent: 2002/0054899 (2002-05-01), D'Amato
patent: 2002/0061923 (2002-05-01), D'Amato
patent: 2002/0131954 (2002-09-01), Tobinick
patent: 2002/0131955 (2002-09-01), Tobinick
patent: 2002/0161023 (2002-10-01), D'Amato
patent: 2002/0173658 (2002-11-01), Muller et al.
patent: 2002/0183360 (2002-12-01), Muller et al.
patent: 2003/0007972 (2003-01-01), Tobinick
patent: 2003/0028028 (2003-02-01), Man et al.
patent: 2003/0045552 (2003-03-01), Robarge et al.
patent: 2003/0049256 (2003-03-01), Tobinick
patent: 2003/0069428 (2003-04-01), Muller et al.
patent: 2003/0087962 (2003-05-01), Demopulos et al.
patent: 2003/0096841 (2003-05-01), Robarge et al.
patent: 2003/0113318 (2003-06-01), Tobinick
patent: 2003/0139451 (2003-07-01), Shah et al.
patent: 2003/0144325 (2003-07-01), Muller et al.
patent: 2003/0181428 (2003-09-01), Green et al.
patent: 2003/0185826 (2003-10-01), Tobinick
patent: 2003/0187024 (2003-10-01), D'Amato
patent: 2003/0191098 (2003-10-01), D'Amato
patent: 2003/0235909 (2003-12-01), Hariri et al.
patent: 2004/0029832 (2004-02-01), Zeldi
patent: 2004/0038874 (2004-02-01), Omoigui
patent: 2004/0077685 (2004-04-01), Figg et al.
patent: 2004/0077686 (2004-04-01), Dannenberg et al.
patent: 2004/0087546 (2004-05-01), Zeldis
patent: 2004/0091455 (2004-05-01), Zeldis
patent: 2004/0122052 (2004-06-01), Muller et al.
patent: WO 98/03502 (1998-01-01), None
patent: WO 98/54170 (1998-12-01), None
patent: WO 00/18409 (2000-04-01), None
patent: WO 02/059106 (2002-08-01), None
patent: WO03086373 (2003-10-01), None
Ignatowski et al. Brain Research (1999), vol. 841, pp. 70-77.
Laffitte et al. Exper. Opin. Drug Saf. (2004), vol. 3, pp. 47-56.
Abbott, F. et al.Pain 60:91-102 (1995).
Arruda, Janice L. et al.,Brain Research, 879, 216-225, 2000.
Bennett G J,Clinical journal of pain, 16(3 Suppl) S139-143, 2000.
Toussirot E., et al.,Expert opinion on investigational drugs, 10(1), 21-9, Jan. 2001.
Carstensen, Jens T.,Drug Stability: Principles&Practice, 2d. Ed., Marcel Dekker, NY, NY, 1995, pp. 379-380.
Corral, L.G. et al., Ann. Rheum. Dis. 58:(Suppl I) 1107-1113 (1999).
Dray, A.,British Journal of-Anaesthesia, 75: 125-131, 1995.
Dzwierzynski et al.,Hand Clinicsvol. 10 (1): 29-44 (1994).
Feng Huang, et al.,Arthritis and rheumatism, 47(3), 249-54, Jun. 2002.
George, et al.,Pain, 88, 267-275, 2000.
Hogan, Q.,Regional Anesthesia and Pain Medicine 27(4):385-401 (2002).
Langerman et al.,Pharmacol. Toxicol. Methods 34:23-27 (1995).
Malmberg, A. and Yaksh, T.,Pain 60:83-90 (1995).
Miller, J.M., et al.,Antibiot. Med. Clin. Ther., 7, 743-746, 1960.
Perez R.S., et al.,J Pain Symptom ManageJun. 2001; 21(6): 511-26.
Rajkumar, S.V., et al.,Archives of internal medicine, 161, 2502-3, Nov. 2001.
Schwartzman R.J.,N Engl J Med343(9): 654 (2000).
Schwartzman R.J.,Curr Opin Neural Neurosurg6(4): 531-6 (1993).
1Burger's Medicinal Chemistry and Drug Discovery, 172-178, 949-982 (Manfred E. Wolff ed., 5th ed. 1995).
N. Ake Jonnson, 1972. “Chemical Structure and Teratogenic Properties,” Acta Pharm., pp. 521-542.
Ji, 2003, “Activation of MAP kinases in primary sensory neurons,” Proc. 10thWorld Congress on Pain, Prog. in Pain Res. and Management vol. 24, Ch. 8, pp. 81-87.
Kenney et al., 1998, “Peripheral axotomy induces long-term c-Jun amino-terminal kinase-I activation and activator protein-I binding activity by c-Jun and junD in adult rat dorsal root ganglia In vivo,” J. Neurosci. 18(4):1318-1328.
Ma et al., 2002, “Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus,” Pain 99(1-2):175-184.
Wagner et al., “Edoneurial injection of TNF-alpha produces neuropathic pain behaviors,” Neuroreport, Nov. 25, 1996;7(18):2897-901.
Faleck Herbert
Manning Donald C.
Zeldis Jerome B.
Celgene Corporation
Day Jones
Lewis Patrick T
LandOfFree
Methods for treatment, modification and management of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treatment, modification and management of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment, modification and management of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4087232